Kepler Capital Markets Analysts Give Rhoen Klinikum (RHK) a €19.00 Price Target

Kepler Capital Markets set a €19.00 ($22.09) price objective on Rhoen Klinikum (ETR:RHK) in a research report sent to investors on Wednesday morning. The brokerage currently has a sell rating on the stock.

RHK has been the topic of several other reports. Cfra set a €22.00 ($25.58) target price on Rhoen Klinikum and gave the stock a sell rating in a research report on Monday, November 12th. Warburg Research set a €25.20 ($29.30) target price on Rhoen Klinikum and gave the stock a neutral rating in a research report on Friday, November 9th. Independent Research set a €24.00 ($27.91) target price on Rhoen Klinikum and gave the stock a neutral rating in a research report on Tuesday, November 13th. Commerzbank set a €19.00 ($22.09) target price on Rhoen Klinikum and gave the stock a sell rating in a research report on Friday, November 16th. Finally, Berenberg Bank set a €23.50 ($27.33) target price on Rhoen Klinikum and gave the stock a neutral rating in a research report on Wednesday, November 14th. Four analysts have rated the stock with a sell rating and four have given a hold rating to the stock. The company has an average rating of Hold and a consensus price target of €21.75 ($25.29).

Shares of ETR:RHK opened at €22.88 ($26.60) on Wednesday. Rhoen Klinikum has a 52-week low of €25.08 ($29.16) and a 52-week high of €32.12 ($37.35).

About Rhoen Klinikum

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Featured Story: Buyback

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply